QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$2.50
$2.74
50-Day Range
N/A
52-Week Range
$47.02
$64.78
Volume
192,659 shs
Average Volume
421,943 shs
Market Capitalization
$74.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67

(ANTX) MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
166.7% Upside
$6.67 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$5.53 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.54) to ($2.28) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.80 out of 5 stars

Medical Sector

652nd out of 930 stocks

Pharmaceutical Preparations Industry

300th out of 433 stocks

ANTX stock logo

About (ANTX) Stock (NYSE:ANTX)

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

ANTX Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
AN2 Therapeutics just downgraded at Evercore ISI, here's why
AN2 Therapeutics just downgraded at Leerink, here's why
AN2 Therapeutics just downgraded at Oppenheimer, here's why
These Biotech Stocks Caught Our Attention - Did You Notice?
See More Headlines
Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/16/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.67
High Stock Price Target
$7.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+166.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$-64,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.19 per share

Miscellaneous

Free Float
24,254,000
Market Cap
$74.43 million
Optionable
Not Optionable
Beta
-0.24
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Joseph R. Swedish (Age 66)
    Exec. Chairman
  • Ms. Gail Koziara Boudreaux (Age 57)
    Pres, CEO & Director
  • Mr. John Edward Gallina (Age 58)
    Exec. VP & CFO
  • Ms. Gloria Marie McCarthy (Age 65)
    Exec. VP and Chief Admin. & Transformation Officer
  • Mr. Peter David Haytaian (Age 48)
    Exec. VP & Pres of Commercial and Specialty Bus. Division

ANTX Stock Analysis - Frequently Asked Questions

Should I buy or sell (ANTX) stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for (ANTX) in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ANTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ANTX, but not buy additional shares or sell existing shares.
View ANTX analyst ratings
or view top-rated stocks.

What is (ANTX)'s stock price target for 2024?

4 brokerages have issued 1-year price objectives for (ANTX)'s shares. Their ANTX share price targets range from $6.00 to $7.00. On average, they expect the company's stock price to reach $6.67 in the next twelve months. This suggests a possible upside of 166.7% from the stock's current price.
View analysts price targets for ANTX
or view top-rated stocks among Wall Street analysts.

When is (ANTX)'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our ANTX earnings forecast
.

What other stocks do shareholders of (ANTX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ANTX) investors own include Intel (INTC), CrowdStrike (CRWD), DocuSign (DOCU), Micron Technology (MU), Valero Energy (VLO), Pfizer (PFE), Align Technology (ALGN), Broadcom (AVGO), Cisco Systems (CSCO) and Datadog (DDOG).

When did (ANTX) IPO?

(ANTX) (ANTX) raised $69 million in an initial public offering on Friday, March 25th 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

This page (NYSE:ANTX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners